Atherosclerotic renal artery stenosis: current status

Adv Chronic Kidney Dis. 2015 May;22(3):224-31. doi: 10.1053/j.ackd.2014.10.004.

Abstract

Atherosclerotic renal artery stenosis (ARAS) remains a major cause of secondary hypertension and kidney failure. Randomized prospective trials show that medical treatment should constitute the main therapeutic approach in ARAS. Regardless of intensive treatment and adequate blood pressure control, however, renal and extrarenal complications are not uncommon. Yet, the precise mechanisms, accurate detection, and optimal treatment in ARAS remain elusive. Strategies oriented to early detection and targeting these pathogenic pathways might prevent development of clinical end points. Here, we review the results of recent clinical trials, current understanding of the pathogenic mechanisms, novel imaging techniques to assess kidney damage in ARAS, and treatment options.

Keywords: Atherosclerosis; Hypertension; Inflammation; Ischemia; Renal artery obstruction.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Angiotensin Receptor Antagonists / therapeutic use*
  • Antihypertensive Agents / therapeutic use*
  • Atherosclerosis / complications
  • Atherosclerosis / diagnosis
  • Atherosclerosis / drug therapy*
  • Calcium Channel Blockers / therapeutic use*
  • Diuretics / therapeutic use*
  • Humans
  • Hypertension / etiology
  • Hypertension / metabolism
  • Hypertension / therapy*
  • Kidney / blood supply
  • Kidney / diagnostic imaging
  • Kidney / pathology
  • Magnetic Resonance Imaging
  • Multidetector Computed Tomography
  • Renal Artery Obstruction / complications
  • Renal Artery Obstruction / diagnosis
  • Renal Artery Obstruction / drug therapy*
  • Renin-Angiotensin System

Substances

  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Diuretics